tykhr
sign in
free sign up
Cerevel Therapeutics Holdings Inc
Biotechnology
Healthcare
CERE
157 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
42.34
52 week high
42.44
high
42.42
52 week low
20.27
low
42.13
growth
28.73 %
previous Close
42.40
P/E ratio
market cap
3.39 B
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-99.54 M
4.56 %
eps
0.00 %
5.97 %
eps surprise
3.08 %
net profit margin
-9953500000.00 %
0.00 %
operating incoming
-96.84 M
2.72 %
net change in cash
22.04 M
27.44 %
cash on hand
176 M
14.27 %
cost of revenue
0.00 %
top